12/22/2022 12:51:27 PM - Reversed and slumped below its 50 DMA line after recently wedging to a new all-time high. Reported earnings +13% on +10% sales revenues for the Sep &#39;22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).<br><hr>12/9/2022 12:16:53 PM - Consolidating after recently rallying to a new all-time high. Reported earnings +13% on +10% sales revenues for the Sep &#39;22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).<br><hr>9/30/2022 11:51:53 AM - Consolidating above its 200 DMA line. Reported earnings +25% on +10% sales revenues for the Jun &#39;22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).<br><hr>9/28/2022 12:14:13 PM - Consolidating above its 200 DMA line. Reported earnings +25% on +10% sales revenues for the Jun &#39;22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).<br><hr>9/9/2022 12:14:46 PM - Consolidating near prior highs in the $240 area and just above its 50 DMA line ($236.55). Reported earnings +25% on +10% sales revenues for the Jun &#39;22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).<br><hr>9/6/2022 12:39:04 PM - Consolidating near prior highs in the $240 area and just above its 50 DMA line ($235). Reported earnings +25% on +10% sales revenues for the Jun &#39;22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).<br><hr>9/2/2022 12:38:44 PM - Consolidating near prior highs in the $240 area. Reported earnings +25% on +10% sales revenues for the Jun &#39;22 quarter versus the year ago period. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).<br><hr>7/21/2022 12:18:40 PM - Met resistance at its 200 DMA line when recently trying to rebound. Reported earnings +17% on +10% sales revenues for the Mar &#39;22 quarter, and prior quarterly comparisons were below the +25% minimum guideline (C criteria).<br><hr>8/1/2019 12:07:13 PM - Testing support at its 50 DMA line ($164.90) today after touching a new all-time high on the prior session but finishing near the bottom of its intra-day trading range. The 7/31/19 mid-day report cautioned members - <i>&quot;Reported earnings +15% on +6% sales revenues for the Jun &#39;19 quarter, its 2nd consecutive comparison below the +25% minimum guideline. Prior quarterly comparisons had better earnings increases. Sub par sales revenues growth remains a concern.&quot; </i><br><hr>7/31/2019 12:27:14 PM - Tested support at its 50 DMA line on the prior session and gapped up today touching a new all-time high.  Reported earnings +15% on +6% sales revenues for the Jun &#39;19 quarter, its 2nd consecutive comparison below the +25% minimum guideline. Prior quarterly comparisons had better earnings increases. Sub par sales revenues growth remains a concern.<br><hr>7/3/2019 11:35:36 AM - Rebounding above its 50 DMA line ($162) after gapping down and undercutting that important moving average on the prior session, retreating from its all-time high.  Reported earnings +13% on +4% sales revenues for the Mar &#39;19 quarter. Prior quarterly comparisons had better earnings increases. Sub par sales revenues growth remains a concern.<br><hr>7/2/2019 12:18:36 PM - Gapped down today violating its 50 DMA line ($162), retreating from its all-time high.  Reported earnings +13% on +4% sales revenues for the Mar &#39;19 quarter. Prior quarterly comparisons had better earnings increases. Sub par sales revenues growth remains a concern.<br><hr>11/16/2018 12:25:36 PM - Consolidating above its 50 DMA line, perched near its all-time high.  Reported strong earnings increases in the Jun and Sep &#39;18 quarters.  Prior quarterly comparisons had sub par earnings and sales revenues growth.<br><hr>